Table 1.
Patient characteristics with advanced NSCLC
| N = 173 (%) | |
|---|---|
|
Age (median, range) |
57 (34–88) |
|
SEX |
|
| Male |
116 (67) |
| Female |
57 (33) |
|
RACE |
|
| African American |
90 (52) |
| White |
83 (48) |
|
Performance status (PS) |
|
| 0-1 |
130 (76) |
| 2-4 |
42 (24) |
|
Histology |
|
| Adenocarcinoma |
91 (52) |
| Non-adenocarcinoma |
82 (47) |
|
Number of metastatic sites |
|
| 1-2 |
93 (54) |
| >2 |
80 (46) |
|
Chemotherapy |
|
| No chemo |
59 (34) |
| Any chemo |
114 (66) |
|
First response assessment |
|
| Response to chemotherapy |
41 (23) |
| Stable disease |
24 (14) |
| Progression |
39 (23) |
| Decline in performance status |
69 (40) |
|
Survival (months) |
|
| Median progression free survival |
3.7 |
| Median overall survival | 5.1 |
NSCLC: Non-small cell lung cancer.